Sulzer AG logo

Sulzer AG (0QQ9)

Market Open
7 Aug, 15:30
LSE LSE
150. 45
CHF
-1
-0.6603%
CHF
- Market Cap
- P/E Ratio
- Div Yield
2,887 Volume
- Eps
151.45 CHF
Previous Close
Add Transaction
Day Range
150 153.9
Year Range
121.6 180.4
Want to track 0QQ9 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0QQ9 trading today lower at 150.45 CHF, a decrease of -0.6603% from yesterday's close, completing a monthly increase of 12.067% or 16.2 CHF. Over the past 12 months, 0QQ9 stock gained 2.907%.
0QQ9 pays dividends to its shareholders, with the most recent payment made on Apr 21, 2026. The next estimated payment will be in In 8 months on Apr 21, 2027 for a total of 4.75 CHF.
The last earnings report, released on Feb 26, 2026, missed the consensus estimates by -4.69%. On average, the company has fell short of earnings expectations by -1.5633%, based on the last three reports.
Sulzer AG has completed 1 stock splits, with the recent split occurring on Apr 14, 2008.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on SIX (CHF).

0QQ9 Chart

Sulzer AG (0QQ9) FAQ

What is the stock price today?

The current price is 150.45 CHF.

On which exchange is it traded?

Sulzer AG is listed on LSE.

What is its stock symbol?

The ticker symbol is 0QQ9.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Sulzer AG ever had a stock split?

Sulzer AG had 1 splits and the recent split was on Apr 14, 2008.

Sulzer AG Profile

Chemicals Industry
Materials Sector
Mr. David John Marsh CEO
LSE Exchange
CH0038388911 ISIN
United Kingdom Country
101 Employees
17 Apr 2026 Last Dividend
14 Apr 2008 Last Split
- IPO Date

Overview

Surgical Innovations Group plc, established in 1988 and headquartered in Leeds, United Kingdom, specializes in the design, manufacture, and global export of medical devices for minimally invasive surgery, including laparoscopic and robotic procedures. The company's operations encompass three primary segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. Surgical Innovations serves a wide range of geographic markets, including the United Kingdom, Europe, the Asia Pacific, the United States, and other international regions. Its products cater to various surgical needs, aiming to enhance the efficiency and safety of minimally invasive procedures.

Products and Services

YelloPort Elite port access systems: These are designed to facilitate entry into the abdominal cavity during laparoscopic surgery, enhancing the procedure's safety and efficiency.

YelloPort +plus Resposable port access systems: These systems combine reusable and disposable components for port access, aiming to offer cost-effectiveness alongside high performance in minimally invasive surgery.

LogiCut: A disposable laparoscopic insert intended for precise cutting during surgery, ensuring safety and reliability.

Logic: Reusable laparoscopic grasping forceps and dissectors, providing durability and precision for various surgical processes.

LogiFlex: A dual-purpose, Resposable device that facilitates blunt dissection and gastric band retrieval, offering versatility in minimally invasive surgical applications.

FastClamp: A reusable laparoscopic clamping system designed for the secure fixation of a range of surgical instruments during procedures, enhancing operational stability.

PretzelFlex: An organ and tissue retractor shaped like a pretzel, specifically created for use in minimally invasive surgery to improve visibility and access during the procedure.

LogiTube: A calibration tubing used for sizing the gastric pouch in various bariatric surgery procedures, including sleeve gastrectomy and mini gastric bypass, contributing to the preciseness and success of the surgery.

In addition to these proprietary products, Surgical Innovations engages in the research, development, manufacture, and distribution of minimally invasive surgical devices for third-party medical companies, either under their own label or through co-branding arrangements. The company also extends its expertise to precision engineering applications outside the medical field. Another key area of service includes the design and manufacturing of instruments and autologous blood products, which further illustrates its diversified approach in catering to the healthcare industry. Distribution of specialist medical products through independent healthcare distributors and OEM relationships enhances the company's reach and scalability.

Contact Information

Address: Clayton Wood House
Phone: 44 11 3230 7597